Surface Oncology | 4:持股變動聲明-董事 Sigal Charles Elliott
Surface Oncology | 4:持股變動聲明-高管 Adams Chandra
Surface Oncology | 4:持股變動聲明-高管 RATH HENRY C.
Surface Oncology | 4:持股變動聲明-董事 Goater Jeff
Surface Oncology | 4:持股變動聲明-首席財務官 FEES JESSICA
Surface Oncology | 4:持股變動聲明-首席執行官 ROSS ROBERT W.
Surface Oncology | 4:持股變動聲明-董事 GRAYZEL DAVID S.
Surface Oncology | 4:持股變動聲明-高管 ONEILL ALISON
Surface Oncology | 4:持股變動聲明-高管 Adams Chandra
Surface Oncology | 4:持股變動聲明-首席財務官 FEES JESSICA
Surface Oncology | 4:持股變動聲明-高管 ONEILL ALISON
Surface Oncology | 4:持股變動聲明-首席執行官 ROSS ROBERT W.
Surface Oncology | SC 13G:超過5%持股股東披露文件-ADAR1 Partners, LP(5.24%),ADAR1 Capital Management, LLC(5.24%)等
Surface Oncology | 4:持股變動聲明-高管 RATH HENRY C.
Surface Oncology | 4:持股變動聲明-首席執行官 ROSS ROBERT W.
Surface Oncology | 4:持股變動聲明-高管 Adams Chandra
Surface Oncology | 4:持股變動聲明-高管 ONEILL ALISON
Surface Oncology | 4:持股變動聲明-首席財務官 FEES JESSICA
Surface Oncology | 4:持股變動聲明-高管 Palombella Vito J.
Surface Oncology | SC 13G/A:超過5%持股股東披露文件(修正)-EcoR1 Capital, LLC(6.5%),Oleg Nodelman(6.5%)等
暫無數據
暫無數據